Merck Publishes 2015/2016 Global Corporate Responsibility Report
13 September 2016 - 11:00PM
Business Wire
Report Highlights Company’s Long-Standing
Commitment to Discovering Innovative and Sustainable Solutions to
the World’s Greatest Health and Development Challenges
Merck (NYSE:MRK), known as MSD outside the United States and
Canada, today issued its 2015/2016 global corporate responsibility
report. The report reflects the company’s performance in the areas
of Access to Health, Environmental Sustainability, Employees and
Ethics & Transparency.
“As we celebrate our company’s 125th anniversary as a global
health care leader, we look forward to building on our history of
innovation and its lasting impact on people and societies around
the world,” said Kenneth C. Frazier, chairman and chief executive
officer, Merck. “Our legacy is a powerful reminder of the
difference great medicines can make in the lives of generations,
and of our responsibility to invest in new solutions to address
tomorrow’s pressing health care needs.”
Making a Difference
Corporate responsibility is at the core of Merck’s mission and
drives us to find solutions to the world’s greatest health
challenges while growing our business in a sustainable way. Our
approach is aligned with our mission and values and focuses on four
key priorities of access to health, environmental sustainability,
employee health and well-being, and ethics and transparency.
Highlights from this year’s report include:
- Advancing our pipeline in areas of
significant unmet medical need, including cancer, the hepatitis C
virus and life-threatening infections;
- Recognizing retired Merck scientist
William C. Campbell, Ph.D., for receiving the 2015 Nobel Prize in
Medicine or Physiology for his discovery leading to a treatment for
river blindness;
- Protecting the lives of mothers and
children through Merck for Mothers, including work with partners to
reduce maternal mortality rates by nearly half in target districts
of Uganda and Zambia, and decreasing stock-outs of contraceptives
in Senegal from more than 80 percent to less than 2 percent
nationwide;
- Launching products and initiatives to
protect the health and well-being of companion animals, food
production animals and equine through our Animal Health business
while supporting the education of the next generation of
veterinarians who will lead the animal health industry in the
future;
- Attaining all three of our
environmental goals ahead of schedule, including a 29 percent
reduction in water use since 2009, and a 22 percent reduction in
greenhouse gas emissions since 2012;
- Significantly increasing business with
diverse suppliers and small enterprises, and instituting a more
formal program to evaluate the risks for labor and human rights
impacts in the supply chain;
- Initiating a volunteerism campaign in
recognition of the company’s 125th anniversary, challenging
employees to report 125,000 volunteer hours to support their local
communities; and
- Launching a comprehensive strategic
plan to attract and retain talent while building an inclusive
workplace where every employee can thrive and where we leverage our
diversity for greater innovations in cutting edge science.
Merck continues to use several external guidelines and
measurement frameworks to inform the scope of its reporting,
including the Global Reporting Initiative, the Sustainable
Development Goals, the Access to Medicine Index and the 10
principles of the United Nations Global Compact.
To find out more, read the 2015/2016 Merck Corporate
Responsibility Report.
About Merck
For 125 years, Merck has been a global health care leader
working to help the world be well. Merck is known as MSD outside
the United States and Canada. Through our prescription medicines,
vaccines, biologic therapies and animal health products, we work
with customers and operate in more than 140 countries to deliver
innovative health solutions. We also demonstrate our commitment to
increasing access to health care through far-reaching policies,
programs and partnerships. For more information, visit
www.merck.com and connect with us on Twitter, Facebook, YouTube and
LinkedIn.
Forward-Looking Statement of Merck & Co., Inc.,
Kenilworth, N.J., USA
This news release of Merck & Co., Inc., Kenilworth, N.J.,
USA (the “company”) includes “forward-looking statements” within
the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995. These statements are
based upon the current beliefs and expectations of the company’s
management and are subject to significant risks and uncertainties.
There can be no guarantees with respect to pipeline products that
the products will receive the necessary regulatory approvals or
that they will prove to be commercially successful. If underlying
assumptions prove inaccurate or risks or uncertainties materialize,
actual results may differ materially from those set forth in the
forward-looking statements.
Risks and uncertainties include but are not limited to, general
industry conditions and competition; general economic factors,
including interest rate and currency exchange rate fluctuations;
the impact of pharmaceutical industry regulation and health care
legislation in the United States and internationally; global trends
toward health care cost containment; technological advances, new
products and patents attained by competitors; challenges inherent
in new product development, including obtaining regulatory
approval; the company’s ability to accurately predict future market
conditions; manufacturing difficulties or delays; financial
instability of international economies and sovereign risk;
dependence on the effectiveness of the company’s patents and other
protections for innovative products; and the exposure to
litigation, including patent litigation, and/or regulatory
actions.
The company undertakes no obligation to publicly update any
forward-looking statement, whether as a result of new information,
future events or otherwise. Additional factors that could cause
results to differ materially from those described in the
forward-looking statements can be found in the company’s 2015
Annual Report on Form 10-K and the company’s other filings with the
Securities and Exchange Commission (SEC) available at the SEC’s
Internet site (www.sec.gov).
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160913005123/en/
MerckMedia:Lainie Keller, 908-236-5036orInvestors:Teri Loxam,
908-740-1986Amy Klug, 908-740-1898
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2024 to May 2024
Merck (NYSE:MRK)
Historical Stock Chart
From May 2023 to May 2024